Page last updated: 2024-08-25

methyl 2,4-dihydroxy-3,6-dimethyl benzoate and Prostatic Neoplasms, Castration-Resistant

methyl 2,4-dihydroxy-3,6-dimethyl benzoate has been researched along with Prostatic Neoplasms, Castration-Resistant in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Adam, L; Ahmad, A; Baniahmad, A; Bartsch, S; Berndt, A; Dittmann, J; Ehsani, M; Grimm, MO; Huettner, SS; Kotolloshi, R; Mosig, AS; Neri, F; Neubert, L; Ori, A; Pungsrinont, T; Rasa, SMM; Schindler, K1
Ghafouri-Fard, S; Hussen, BM; Rashnoo, F; Safarzadeh, A; Taheri, M1

Other Studies

2 other study(ies) available for methyl 2,4-dihydroxy-3,6-dimethyl benzoate and Prostatic Neoplasms, Castration-Resistant

ArticleYear
The natural compound atraric acid suppresses androgen-regulated neo-angiogenesis of castration-resistant prostate cancer through angiopoietin 2.
    Oncogene, 2022, Volume: 41, Issue:23

    Topics: Androgen Receptor Antagonists; Androgens; Angiopoietin-2; Animals; Cell Line, Tumor; Endothelial Cells; Humans; Hydroxybenzoates; Male; Mice; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Vascular Endothelial Growth Factor A

2022
In silico characterization of competing endogenous RNA network in castration-resistant prostate cancer cells in presence of the natural compound atraric acid using RNA-seq analysis.
    Pathology, research and practice, 2022, Volume: 240

    Topics: Humans; Hydroxybenzoates; Male; Prostatic Neoplasms, Castration-Resistant; RNA, Long Noncoding; Sequence Analysis, RNA

2022